NEPHROS, INC. Impairment of Long-Lived Assets Held-for-use
NEPHROS, INC. (NEPH) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-03-12
- NEPHROS, INC. impairment of long-lived assets held-for-use for the quarter ending 2022-12-31 was $0.00.
- NEPHROS, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- NEPHROS, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- NEPHROS, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- NEPHROS, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $1.40M.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-24 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.40M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $1.40M 10-Q · filed 2023-11-08 | ||
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |